354 related articles for article (PubMed ID: 17805347)
1. T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes.
Muntasell A; Berger AC; Roche PA
EMBO J; 2007 Oct; 26(19):4263-72. PubMed ID: 17805347
[TBL] [Abstract][Full Text] [Related]
2. Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells.
Hong J; Persaud SP; Horvath S; Allen PM; Evavold BD; Zhu C
J Immunol; 2015 Oct; 195(8):3557-64. PubMed ID: 26336148
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
[TBL] [Abstract][Full Text] [Related]
4. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
5. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
Bosch B; Heipertz EL; Drake JR; Roche PA
J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
Cho KJ; Walseng E; Ishido S; Roche PA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
[TBL] [Abstract][Full Text] [Related]
7. The dependence for leukocyte function-associated antigen-1/ICAM-1 interactions in T cell activation cannot be overcome by expression of high density TCR ligand.
Abraham C; Griffith J; Miller J
J Immunol; 1999 Apr; 162(8):4399-405. PubMed ID: 10201975
[TBL] [Abstract][Full Text] [Related]
8. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers.
Holland CJ; Dolton G; Scurr M; Ladell K; Schauenburg AJ; Miners K; Madura F; Sewell AK; Price DA; Cole DK; Godkin AJ
J Immunol; 2015 Dec; 195(12):5827-36. PubMed ID: 26553072
[TBL] [Abstract][Full Text] [Related]
10. Costimulation and endogenous MHC ligands contribute to T cell recognition.
Wülfing C; Sumen C; Sjaastad MD; Wu LC; Dustin ML; Davis MM
Nat Immunol; 2002 Jan; 3(1):42-7. PubMed ID: 11731799
[TBL] [Abstract][Full Text] [Related]
11. Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells.
Ishikawa R; Kajikawa M; Ishido S
Int Immunol; 2014 May; 26(5):283-9. PubMed ID: 24370470
[TBL] [Abstract][Full Text] [Related]
12. Increased numbers and suppressive activity of regulatory CD25(+)CD4(+) T lymphocytes in the absence of CD4 engagement by MHC class II molecules.
Shen X; Niu C; König R
Cell Immunol; 2013 Apr; 282(2):117-28. PubMed ID: 23770721
[TBL] [Abstract][Full Text] [Related]
13. Peptide-specific intercellular transfer of MHC class II to CD4+ T cells directly from the immunological synapse upon cellular dissociation.
Wetzel SA; McKeithan TW; Parker DC
J Immunol; 2005 Jan; 174(1):80-9. PubMed ID: 15611230
[TBL] [Abstract][Full Text] [Related]
14. Murine CD4+ T cells undergo TCR-activated adhesion to extracellular matrix proteins but not to nonantigenic MHC class II proteins.
O'Rourke AM; Lasam MC
J Immunol; 1995 Oct; 155(8):3839-46. PubMed ID: 7561090
[TBL] [Abstract][Full Text] [Related]
15. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
Dembic Z; Schenck K; Bogen B
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
[TBL] [Abstract][Full Text] [Related]
18. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude.
Moon JJ; Chu HH; Pepper M; McSorley SJ; Jameson SC; Kedl RM; Jenkins MK
Immunity; 2007 Aug; 27(2):203-13. PubMed ID: 17707129
[TBL] [Abstract][Full Text] [Related]
19. The minimal number of antigen-major histocompatibility complex class II complexes required for activation of naive and primed T cells.
Kimachi K; Croft M; Grey HM
Eur J Immunol; 1997 Dec; 27(12):3310-7. PubMed ID: 9464819
[TBL] [Abstract][Full Text] [Related]
20. The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation.
Vascotto F; Lankar D; Faure-André G; Vargas P; Diaz J; Le Roux D; Yuseff MI; Sibarita JB; Boes M; Raposo G; Mougneau E; Glaichenhaus N; Bonnerot C; Manoury B; Lennon-Duménil AM
J Cell Biol; 2007 Mar; 176(7):1007-19. PubMed ID: 17389233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
